Compare · CVII vs DALS
CVII vs DALS
Side-by-side comparison of Churchill Capital Corp VII (CVII) and DA32 Life Science Tech Acquisition Corp. (DALS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVII and DALS operate in Blank Checks (Finance), so they compete in similar markets.
- CVII is the larger of the two at $1.68B, about 6.8x DALS ($246.0M).
Churchill Capital Corp VII
Churchill Capital Corp VII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
DA32 Life Science Tech Acquisition Corp.
DA32 Life Science Tech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Latest CVII
- Amendment: SEC Form SC 13G/A filed by Churchill Capital Corp VII
- SEC Form 15-12G filed by Churchill Capital Corp VII
- Large owner Magnetar Financial Llc disposed of $90,084,438 worth of shares (8,306,005 units at $10.85) (SEC Form 4)
- Churchill Capital Corp VII filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Churchill Capital Corp VII
- Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination
- SEC Form 10-Q filed by Churchill Capital Corp VII
- Churchill Capital Corp VII filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Churchill Capital Corp VII
- SEC Form DEFA14A filed by Churchill Capital Corp VII
Latest DALS
- SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
- SEC Form 4: Crandell Keith disposed of 1,600,000 shares
- SEC Form 4: Arch Venture Fund Xi, L.P. disposed of 1,600,000 shares
- SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by DA32 Life Science Tech Acquisition Corp.
- SEC Form SC 13D/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
- SEC Form SC 13D/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
- SEC Form 4: Deerfield Management Company, L.P. (Series C) disposed of 1,600,000 shares
- SEC Form SC 13D/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)